File Download
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Neuroprotective effects of melatonin and calpeptin in a rat model of focal cerebral ischemia
Title | Neuroprotective effects of melatonin and calpeptin in a rat model of focal cerebral ischemia |
---|---|
Authors | |
Issue Date | 2014 |
Publisher | Hong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org.hk |
Citation | The 19th Medical Research Conference, Department of Medicine, The University of Hong Kong, Hong Kong, China, 18 January 2014. In Hong Kong Medical Journal, 2014, v. 20 n. Suppl. 1, p. 18, abstract no. 19 How to Cite? |
Abstract | Introduction: Melatonin is a potent-free radical scavenger and antioxidant. Previously, we have demonstrated
beneficial effects of pretreatment with melatonin in mild and severe focal cerebral ischaemia in rodent models.
Cerebral ischaemia increases intracellular Ca2+ concentrations, and activates several calcium-dependent
proteases including calpain. Pretreatment with calpeptin, a novel calpain inhibitor, has been reported to
reduce the cerebral infarct volume. In addition, it also decreases the neuronal apoptosis in hippocampal CA1
sector and improves the behavioural deficit in a rat stroke model. The aim of this study was to investigate the
neuroprotective role of a post-ischaemia treatment with melatonin and / or calpeptin, and whether combining
the two exerts synergistic or addictive effects in transient focal ischaemic stroke in rats.
Methods: Male Sprague-Dawley rats (6-8 weeks) were anaesthetised with sodium pentobarbital to undergo
right-sided endovascular middle cerebral artery occlusion (MCAO) for 90 minutes followed by 24 hours of
reperfusion before being sacrificed. A single or a combined dose of melatonin (50 μg/kg) and / or calpeptin
(50 μg/kg) were given via an intracerebroventricular injection at 10-15 minutes after onset of the reperfusion.
Sham group with injection of vehicle only was used as a control group. Neurological behaviour was assessed
using Neurological Deficit Scoring System (NDSS) test and cerebral infarction volumes were evaluated by TTCstaining.
Results: Infarction volumes and NDSS scores were lower in the calpeptin group but not in melatonin group
when compared with the control. The combining effects of melatonin and calpeptin will be studied further.
Conclusion: Our results suggest that post-ischaemia treatment with calpeptin but not melatonin at 50 μg/kg
protects against focal MCAO model in rats. |
Persistent Identifier | http://hdl.handle.net/10722/204268 |
ISSN | 2023 Impact Factor: 3.1 2023 SCImago Journal Rankings: 0.261 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Feng, Y | en_US |
dc.contributor.author | Cheung, RTF | en_US |
dc.date.accessioned | 2014-09-19T21:43:13Z | - |
dc.date.available | 2014-09-19T21:43:13Z | - |
dc.date.issued | 2014 | en_US |
dc.identifier.citation | The 19th Medical Research Conference, Department of Medicine, The University of Hong Kong, Hong Kong, China, 18 January 2014. In Hong Kong Medical Journal, 2014, v. 20 n. Suppl. 1, p. 18, abstract no. 19 | en_US |
dc.identifier.issn | 1024-2708 | - |
dc.identifier.uri | http://hdl.handle.net/10722/204268 | - |
dc.description.abstract | Introduction: Melatonin is a potent-free radical scavenger and antioxidant. Previously, we have demonstrated beneficial effects of pretreatment with melatonin in mild and severe focal cerebral ischaemia in rodent models. Cerebral ischaemia increases intracellular Ca2+ concentrations, and activates several calcium-dependent proteases including calpain. Pretreatment with calpeptin, a novel calpain inhibitor, has been reported to reduce the cerebral infarct volume. In addition, it also decreases the neuronal apoptosis in hippocampal CA1 sector and improves the behavioural deficit in a rat stroke model. The aim of this study was to investigate the neuroprotective role of a post-ischaemia treatment with melatonin and / or calpeptin, and whether combining the two exerts synergistic or addictive effects in transient focal ischaemic stroke in rats. Methods: Male Sprague-Dawley rats (6-8 weeks) were anaesthetised with sodium pentobarbital to undergo right-sided endovascular middle cerebral artery occlusion (MCAO) for 90 minutes followed by 24 hours of reperfusion before being sacrificed. A single or a combined dose of melatonin (50 μg/kg) and / or calpeptin (50 μg/kg) were given via an intracerebroventricular injection at 10-15 minutes after onset of the reperfusion. Sham group with injection of vehicle only was used as a control group. Neurological behaviour was assessed using Neurological Deficit Scoring System (NDSS) test and cerebral infarction volumes were evaluated by TTCstaining. Results: Infarction volumes and NDSS scores were lower in the calpeptin group but not in melatonin group when compared with the control. The combining effects of melatonin and calpeptin will be studied further. Conclusion: Our results suggest that post-ischaemia treatment with calpeptin but not melatonin at 50 μg/kg protects against focal MCAO model in rats. | - |
dc.language | eng | en_US |
dc.publisher | Hong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org.hk | - |
dc.relation.ispartof | Hong Kong Medical Journal | en_US |
dc.rights | Hong Kong Medical Journal. Copyright © Hong Kong Academy of Medicine Press. | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.title | Neuroprotective effects of melatonin and calpeptin in a rat model of focal cerebral ischemia | en_US |
dc.type | Conference_Paper | en_US |
dc.identifier.email | Cheung, RTF: rtcheung@hku.hk | en_US |
dc.identifier.authority | Cheung, RTF=rp00434 | en_US |
dc.description.nature | published_or_final_version | - |
dc.identifier.hkuros | 236233 | en_US |
dc.identifier.volume | 20 | en_US |
dc.identifier.issue | Suppl. 1 | en_US |
dc.identifier.spage | 18, abstract no. 19 | en_US |
dc.identifier.epage | 18, abstract no. 19 | en_US |
dc.publisher.place | Hong Kong | - |
dc.identifier.issnl | 1024-2708 | - |